Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conferences:
-
Stifel 2022 Healthcare Conference, New-York
Event Date: November 15-16, 2022 (in-person event)
-
Evercore ISI 5th Annual HealthConX Conference
Event Date: November 29 – December 1, 2022 (virtual)
| Press Release in English | 312.77 KB |
| Communiqué de presse en français | 316.04 KB |